Trial · NCT03129100
Results by group91
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 91
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Who do Not Experience a Flare (Combined Ixekizumab Treatment) | Combined IXE | 83.3 | Percentage of participants | ||
| Percentage of Participants Who do Not Experience a Flare (Combined Ixekizumab Treatment) | Placebo | 54.7 | Percentage of participants | ||
| Percentage of Participants Who do Not Experience a Flare | IXE80Q4W | 83.3 | Percentage of participants | ||
| Percentage of Participants Who do Not Experience a Flare | IXE80Q2W | 83.3 | Percentage of participants | ||
| Percentage of Participants Who do Not Experience a Flare | Placebo | 54.7 | Percentage of participants | ||
| Change From Baseline in Modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) | IXE80Q4W | 0.41 | Standard Deviation 2.102 | Units on a Scale | |
| Change From Baseline in Modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) | IXE80Q2W | 0.23 | Standard Deviation 1.387 | Units on a Scale | |
| Change From Baseline in Modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) | Combined IXE | 0.32 | Standard Deviation 1.779 | Units on a Scale | |
| Percentage of Participants Achieving an Assessment of Spondyloarthritis International Society (ASAS)20 Response | IXE80Q4W | 81.3 | Percentage of participants | ||
| Percentage of Participants Achieving an Assessment of Spondyloarthritis International Society (ASAS)20 Response | IXE80Q2W | 81.5 | Percentage of participants | ||
| Percentage of Participants Achieving an Assessment of Spondyloarthritis International Society (ASAS)20 Response | Placebo | 50.9 | Percentage of participants | ||
| Percentage of Participants Achieving an ASAS40 Response | IXE80Q4W | 79.2 | Percentage of Participants | ||
| Percentage of Participants Achieving an ASAS40 Response | IXE80Q2W | 79.6 | Percentage of Participants | ||
| Percentage of Participants Achieving an ASAS40 Response | Placebo | 43.4 | Percentage of Participants | ||
| Percentage of Participants With Change of Ankylosing Spondylitis Disease Activity Score (ASDAS) ≥1.1 Units | IXE80Q4W | 79.2 | Percentage of participants | ||
| Percentage of Participants With Change of Ankylosing Spondylitis Disease Activity Score (ASDAS) ≥1.1 Units | IXE80Q2W | 74.1 | Percentage of participants | ||
| Percentage of Participants With Change of Ankylosing Spondylitis Disease Activity Score (ASDAS) ≥1.1 Units | Placebo | 45.3 | Percentage of participants | ||
| Percentage of Participants With Inactive Disease on the ASDAS (<1.3 Units) | IXE80Q4W | 60.4 | Percentage of participants | ||
| Percentage of Participants With Inactive Disease on the ASDAS (<1.3 Units) | IXE80Q2W | 53.7 | Percentage of participants | ||
| Percentage of Participants With Inactive Disease on the ASDAS (<1.3 Units) | Placebo | 24.5 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03129100/results